This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
Categories
Clinical indications, patient selection and the limitations of transanal TME
Posted in Lectures on 8 September 2016
Justin A. Maykel (Chief, Division of Colorectal Surgery)
UMass Memorial Medical Center, Massachusetts – USA
181205818

Only logged in users can watch the full video
A small part is available for preview

Only logged in users can watch the full video

The TME has been the gold standard for surgical treatment of rectal cancer since the 80s. This operation should be performed by experienced surgeons to achieve a favorable oncological outcome and avoid complications such as leaks, urinary / sexual dysfunction, fecal incontinence, pain, prolonged recovery, etc.

Technological improvements and the evolution of surgical skills have led to a progression from an open approach to the laparoscopic approach to radical rectal cancer surgery, which has led a decreased complications rate.

The current era has moved one step forward in terms of the approach to perform the TME: the trans anal approach, which represents a solution to many issues not solved by previous minimally invasive approaches. In this lecture, Justin A. Maykel from UMass Memorial Medical Center, Massachusetts – USA talks about Clinical indications, patient selection and the limitations of transanal TME.